Literatur
- 1
McNay M B, Fleming J EE.
Forty years of obstetric ultrasound 1957–1997: From A-scope to three dimensions.
Ultrasound in Med Biol.
1997;
25
3-56
- 2
Nicolaides K H, Azar G, Byrne D. et al .
Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester
of pregnancy.
Brit Med J.
1992;
304
867-869
- 3
Brizot M L, Snijders R J, Bersinger N A. et al .
Maternal serum pregnancy-associated plasma protein A and fetal nuchal translucency
thickness for the prediction of fetal trisomies in early pregnancy.
Obstet Gynecol.
1994;
418
918-922
- 4
Brizot M L, Snijders R L, Butler J. et al .
Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal
trisomies in the first trimester of pregnancy.
Br J Obstet Gynaecol.
1995;
102
127-132
- 5
Nicolaides K H.
Screening for chromosomal defects.
Ultrasound Obstet Gynecol.
2003;
21
313-321
- 6
Falcon O, Faiola S, Huggon I. et al .
Fetal tricuspid regurgitation at the 11 + 0 to 13 + 6-week scan: association with
chromosomal defects and reproducibility of the method.
Ultrasound Obstet Gynecol.
2006;
27
609-612
- 7
Chasen S T, McCullough L B, Chervenak F A.
Is nuchal translucency screening associated with different rates of invasive testing
in an older obstetric population?.
Am J Obstet Gynecol.
2004;
190
769-774
- 8
Miyake H, Nakai A, Shimada T, Takeshita T.
Effect of first-trimester ultrasound examination for chromosomal aberrations in women
undergoing amniocentesis.
J Nippon Med Sch.
2006;
73
271-276
- 9
Caughey A B, Musci T J, Belluomini J ,. et al .
Nuchal translucency screening: how do women actually utilize the results?.
Prenatal Diagn.
2007;
27
119-123
- 10
Caughey A B, Hopkins L M, Norton M E.
Chorionic villus sampling compared with amniocentesis and the difference in the rate
pregnancy loss.
Obstet Gynecol.
2006;
108
612-616
- 11
Bilardo C M, Müller M A, Pajkrt E. et al .
Increased nuchal translucency and normal karyotype: time for parental reassurance.
Ultrasound Obstet Gynecol.
2007;
30
11-18
- 12
Saltvedt S, Almstrom H, Kublickas M. et al .
Detection of malformations in chromosomally normal fetuses by routine ultrasound at
12 or 18 weeks of gestation – a randomised controlled trial in 39 572 pregnancies.
Brit J Obstet Gynaecol.
2006;
113
664-674
- 13
Olesen A W, Thomsen S G.
Prediction of delivery date by sonography in the first and second trimesters.
Ultrasound Obstet Gynecol.
2006;
28
292-297
- 14
Malone F D, Canick J A, Ball R H. et al .
First- and Second-Trimester Evaluation of Risk (FASTER Research Consortium: First-trimester
or second-trimester screening, or both, for Down's syndrome.
N Engl J Med.
2005;
353
2001-2011
- 15
Wald N J, Rodeck C, Hackshaw. et al .
First and second trimester antenatal screening for Down's syndrome: the results of
the Serum, Urine and Ultrasound Screening Study (SURUSS).
Health Technol Assess.
2003;
7
1-77
- 16
Kowalcek I, Lammers C, Brunk J. et al .
Fears of pregnant women if prenatal examination yields or does not yield any findings.
Zentralbl Gynecol.
2002;
124
170-175
- 17
Filly R A.
Obstetrical sonography: the best way to terrify a pregnant woman.
J Ultrasound Med.
2000;
19
1-5
- 18
Cicero S, Sacchini C, Rembouskos G, Nicolaides K H.
Sonographic markers of fetal aneuploidy – a review.
Placenta.
2003;
24
88-98
- 19
Vintzileos A M, Guzman E R, Smulian J C. et al .
Choice of second-trimester genetic sonogram for detection of trisomy 21.
Obstet Gynecol.
1997;
90
187-190
- 20
Vintzileos A M, Guzman E R, Smulian J C. et al .
Down syndrome risk estimation after normal genetic sonography.
Am J Obstet Gynecol.
2002;
187
1226-1229
- 21
Nijhuis I J, ten Hof J, Mulder E J. et al .
Fetal heart rate in relation to its variation in normal and growth retarded fetuses.
Eur J Obstet Gynecol Reprod Biol.
2000;
89
27-33
- 22
Vindla S, James D, Sahota D.
Computerised analysis of unstimulated and stimulated behaviour in fetuses with intrauterine
growth restriction.
Eur J Obstet Gynecol Reprod Biol.
1999;
83
37-45
- 23
Dawes G S, Moulden M, Redman C W.
System 8000: computerized antenatal FHR analysis.
J Perinat Med.
1991;
19
47-51
- 24
Dawes G S, Moulden M, Redman C W.
Computerized analysis of antepartum fetal heart rate.
Am J Obstet Gynecol.
1995;
173
1353-1354
- 25
Manning F A.
Fetal biophysical profile: a critical appraisal.
Clin Obstet Gynecol.
2002;
45
975-985
- 26
Vintzileos A M, Campbell W A, Rodis J F.
Fetal biophysical profile scoring: current status.
Clin Perinatol.
1989;
16
661-689
- 27
Harman C R, Baschat A A.
Comprehensive assessment of fetal wellbeing: which Doppler tests should be performed?.
Curr Opin Obstet Gynecol.
2003;
15
147-157
- 28
Baschat A A.
Doppler application in the delivery timing of the preterm growth-restricted fetus:
another step in the right direction.
Ultrasound Obstet Gynecol.
2004;
23
111-118
- 29
Maulik D.
Management of fetal growth restriction: an evidence-based approach.
Clin Obstet Gynecol.
2006;
49
320-334
- 30
Baschat A A, Gembruch U, Gortner L. et al .
Coronary artery blood flow visualization signifies hemodynamic deterioration in growth-restricted
fetuses.
Ultrasound Obstet Gynecol.
2000;
16
425-431
- 31
Sedgmen B, McMahon C, Cairns D. et al .
The impact of two-dimensional versus three-dimensional ultrasound exposure on maternal-fetal
attachment and maternal health behaviour in pregnancy.
Ultrasound Obstet Gynecol.
2006;
27
245-251
- 32
Pretorius D H, Gattu S, Ji E K. et al .
Preexamination and postexamination assessment of parental-fetal bonding in patients
undergoing 3- / 4-dimensional obstetric ultrasonography.
J Ultrasound Med.
2006;
25
1411-1421
- 33
Kurjak A, Miskovic B, Andonotopo W. et al .
How useful is 3D and 4D ultrasound in perinatal medicine?.
J Perinat Med.
2007;
35
10-27
Korrespondenzadresse
Priv. Doz. Dr. med. M. Krapp
Zentrum für Pränatale Medizin · Endokrinologikum Hamburg
Lornsenstr. 4–6
22767 Hamburg
Email: martin.krapp@endokrinologikum.com
